Resources

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It offers practical information to countries that plan to pilot, expand, or scale up human papillomavirus (HPV) vaccination programs. The main focus is on issues specific to HPV vaccination, such as working with a young adolescent target population in school settings and developing community support for HPV vaccination programs.

To foster the development of products that could help increase access to safe water at the household level, PATH created guidelines for designing and developing household devices for treating unsafe water and safely storing it for use. The guidelines provide evidence-based criteria for effective, commercially viable products that meet or exceed user expectations for long-term use in resource-limited settings.

This report is a synthesis of the project Evaluating HPV Vaccine Delivery Strategies in Vietnam, which aimed to identify appropriate strategies for human papillomavirus (HPV) vaccine delivery in different geographic and socioeconomic conditions. The report summarizes results of both the implementation and research aspects of the project. The document is available as one large file or as four smaller files for easier downloading.

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

This issue of PATH Today focuses on the launch of the MenAfriVac™ vaccine, the first meningitis vaccine created specifically for Africa. The issue includes a timeline of meningitis in Africa and the development of the vaccine, how PATH partnered with other organizations to create an affordable solution, and a glimpse of what life is like in the "meningitis belt."